Business
Up 36% in a year, why this $8 billion ASX 200 stock has still a ‘strong growth forecast’
Image source: Getty Images
Looking for a quality, under-the-radar S&P/ASX 200 Index (ASX: XJO) stock with strong forecast revenue growth?
Then you may want to check out Telix Pharmaceuticals Ltd (ASX: TLX).
Shares in the diagnostic and therapeutic product developer closed on Friday trading for…
Continue Reading
-
Noosa News21 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business22 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News18 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business21 hours agoEverything you need to know about the Coles dividend